KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Dividends Paid - Common (2016 - 2025)

Historic Dividends Paid - Common for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $1.0 billion.

  • Abbott Laboratories' Dividends Paid - Common rose 739.58% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 billion, marking a year-over-year increase of 738.18%. This contributed to the annual value of $3.8 billion for FY2024, which is 787.4% up from last year.
  • According to the latest figures from Q3 2025, Abbott Laboratories' Dividends Paid - Common is $1.0 billion, which was up 739.58% from $1.0 billion recorded in Q2 2025.
  • Abbott Laboratories' Dividends Paid - Common's 5-year high stood at $1.0 billion during Q3 2025, with a 5-year trough of $798.0 million in Q4 2021.
  • Its 5-year average for Dividends Paid - Common is $894.2 million, with a median of $888.0 million in 2023.
  • As far as peak fluctuations go, Abbott Laboratories' Dividends Paid - Common surged by 2539.18% in 2021, and later surged by 311.33% in 2022.
  • Over the past 5 years, Abbott Laboratories' Dividends Paid - Common (Quarter) stood at $798.0 million in 2021, then increased by 3.13% to $823.0 million in 2022, then rose by 7.9% to $888.0 million in 2023, then grew by 7.88% to $958.0 million in 2024, then rose by 7.62% to $1.0 billion in 2025.
  • Its last three reported values are $1.0 billion in Q3 2025, $1.0 billion for Q2 2025, and $1.0 billion during Q1 2025.